Clinical Significance of Quantitative HBsAg Titres and its Correlation With HBV DNA Levels in the Natural History of Hepatitis B Virus Infection

Journal of Clinical and Experimental Hepatology

Volumn 6, Issue 3, 2016, Pages 209-215

  Karra, Vijay K ^a   Chowdhury, Soumya J ^a   Ruttala, Rajesh ^a   Polipalli, Sunil K ^a   Kar, Premashis ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

HBeAg; HBsAg; HBV DNA quantitative; hepatitis B virus; quantitative HBsAg

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; FEMALE; HEPATITIS B; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VIRUS LOAD; VIRUS REPLICATION;

EID: 84991721169     PISSN: 09736883     EISSN: 22133453     Source Type: Journal    
DOI: 10.1016/j.jceh.2016.07.002     Document Type: Article

References (26)

1. 1 Maini, M.K., Peppa, D., NK cells: a double-edged sword in chronic hepatitis B virus infection. Front Immunol(March), 2013, 4 Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585438/ [cited 07.10.14].
2. 2 McMahon, B.J., The natural history of chronic hepatitis B virus infection. Semin Liver Dis 24:suppl 1 (2004), 17–21.
3. 3 Nguyen, D.H., Ludgate, L., Hu, J., Hepatitis B virus-cell interactions and pathogenesis. J Cell Physiol 216:August (2) (2008), 289–294.
4. 4 Op den Brouw, M.L., Binda, R.S., van Roosmalen, M.H., et al. Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus. Immunology 126:February (2) (2009), 280–289.
5. 5 Chan, H.L.-Y., Thompson, A., Martinot-Peignoux, M., et al. Hepatitis B surface antigen quantification: why and how to use it in 2011 – a core group report. J Hepatol 55:November (5) (2011), 1121–1131.
6. 6 Nguyen, T., Desmond, P., Locarnini, S., The role of quantitative hepatitis B serology in the natural history and management of chronic hepatitis B. Hepatol Int 3:December (suppl 1) (2009), 5–15.
7. 8 Chan, H.L.-Y., Wong, V.W.-S., Wong, G.L.-H., Tse, C.-H., Chan, H.-Y., Sung, J.J.-Y., A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B. Hepatol Baltim Md 52:October (4) (2010), 1232–1241.
8. 9 Jaroszewicz, J., Calle Serrano, B., Wursthorn, K., et al. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. J Hepatol 52:April (4) (2010), 514–522.
9. 10 Nguyen, T., Thompson, A.J.V., Bowden, S., et al. Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol 52:April (4) (2010), 508–513.
10. 11 Manesis, E.K., Hadziyannis, E.S., Angelopoulou, O.P., Hadziyannis, S.J., Prediction of treatment-related HBsAg loss in HBeAG-negative chronic hepatitis B: a clue from serum HBsAg levels. Antivir Ther 12:1 (2007), 73–82.
11. 12 Brunetto, M.R., Moriconi, F., Bonino, F., et al. Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B. Hepatol Baltim Md 49:April (4) (2009), 1141–1150.
12. 13 Moucari, R., Mackiewicz, V., Lada, O., et al. Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients. Hepatol Baltim Md 49:April (4) (2009), 1151–1157.
13. 14 Thompson, A., Locarnini, S., Visvanathan, K., The natural history and the staging of chronic hepatitis B: time for reevaluation of the virus-host relationship based on molecular virology and immunopathogenesis considerations?. Gastroenterology 133:September (3) (2007), 1031–1035.
14. 15 Fattovich, G., Bortolotti, F., Donato, F., Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 48:February (2) (2008), 335–352.
15. 16 European Association For The Study Of The Liver, EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 57:July (1) (2012), 167–185.
16. 17 Deguchi, M., Yamashita, N., Kagita, M., et al. Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay. J Virol Methods 115:February (2) (2004), 217–222.
17. 18 Blumberg, B.S., Sutnick, A.I., London, W.T., Hepatitis and leukemia: their relation to Australia antigen. Bull N Y Acad Med 44:December (12) (1968), 1566–1586.
18. 19 Wursthorn, K., Jung, M., Manns, M., Lopez, P., Wedemeyer, H., Naoumov, N., 17 kinetics of HBsAg decline in HBeAg+ chronic hepatitis B patients with 3 years of telbivudine treatment during the globe study. J Hepatol, 50(April), 2009, S9.
19. 20 Borgniet, O., Parvaz, P., Bouix, C., et al. Clearance of serum HBsAg and anti-HBs seroconversion following antiviral therapy for chronic hepatitis B. J Med Virol 81:August (8) (2009), 1336–1342.
20. 21 Rodella, A., Galli, C., Terlenghi, L., Perandin, F., Bonfanti, C., Manca, N., Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B. J Clin Virol Off Publ Pan Am Soc Clin Virol 37:November (3) (2006), 206–212.
21. 22 Chen, C.-H., Lee, C.-M., Wang, J.-H., Tung, H.-D., Hung, C.-H., Lu, S.-N., Correlation of quantitative assay of hepatitis B surface antigen and HBV DNA levels in asymptomatic hepatitis B virus carriers. Eur J Gastroenterol Hepatol 16:November (11) (2004), 1213–1218.
22. 23 Kim, Y.J., Cho, H.C., Choi, M.S., et al. The change of the quantitative HBsAg level during the natural course of chronic hepatitis B. Liver Int Off J Int Assoc Study Liver 31:July (6) (2011), 817–823.
23. 24 Hadziyannis, S.J., Vassilopoulos, D., Hepatitis B e antigen-negative chronic hepatitis B. Hepatol Baltim Md 34:October (4 Pt 1) (2001), 617–624.
24. 25 Antaki, N., Zeidane, N., Alhaj, N., et al. HBsAg titers in the different phases of hepatitis B infection in Syrian patients. J Clin Virol Off Publ Pan Am Soc Clin Virol 53:January (1) (2012), 60–64.
25. 26 Zeng, L.-Y., Lian, J.-S., Chen, J.-Y., et al. Hepatitis B surface antigen levels during natural history of chronic hepatitis B: a Chinese perspective study. World J Gastroenterol Wjg 20:July (27) (2014), 9178–9184.
26. 27 Chattopadhyay, S., Das, B.C., Kar, P., Hepatitis B virus genotypes in chronic liver disease patients from New Delhi, India. World J Gastroenterol Wjg 12:November (41) (2006), 6702–6706.